Background: Patients with acromegaly are reported to have a higher prevalence of colorectal adenoma, which is a pre-
Introduction
Acromegaly is known to be associated with an increased risk of developing colonic tumors which could be sometimes premalignant. Several studies on prevalence of colorectal polyps in patients with acromegaly from western world, report widely between 23% and 53% (1) (2) (3) (4) (5) . It has been recommended that patients with acromegaly should undergo colonoscopic surveillance from the age of 40 years onwards and thereafter regularly every two to three years if an adenoma is found (6) .
Acromegaly, a disorder of growth hormone (GH) hyper secretion is usually caused by pituitary somatotropinoma. Acromegaly induces the increased generation of insulinlike growth factor-1 (IGF-1) which may be involved in the process of development of colonic polyps (1) (2) (3) (4) (5) . Both GH and IGF-1 are known to promote cellular growth and proliferation and proto-oncogene expression (6) . Studies have shown GH induced expression of oncogenes in many mammalian tissues and also has confirmed the presence of IGF-1 receptors on colonic tissue (7) . This descriptive study was undertaken to define the prevalence of colorectal adenomas among patients with acromegaly following Endocrine and pituitary clinics at National Hospital of Sri Lanka.
Objectives

General Objective
To describe the prevalence of colonic polyps in patients with acromegaly and associated factors.
Specific Objectives
To describe the prevalence of colonic polyps in patients with acromegaly. To describe the associated factors to colonic polyp.
Methodology Study design, Study setting and Study population
This was a descriptive cross-sectional study conducted in the Endocrinology and Pituitary clinics at National Hospital of Sri Lanka between January 2012 and June 2013. From a total of 72 patients with acromegaly, 33 patients (13 males and 20 females), were enrolled for the study. Age group of this sample was 29 to 71 years. The diagnosis of acromegaly was made on clinical grounds, supported by increased basal growth hormone (GH) levels and non-suppressible plasma GH (normal:<1 mU/L) after a 75 g oral glucose load. A data sheet was used for data collection and data gathered from clinic records with regard to the following aspects. Age on presentation, sex, basal circulating plasma GH levels, non-suppressible plasma GH after 75 g oral glucose load, details of the pituitary tumour and duration of GH exposure were recorded. Duration of GH exposure was based on the lag time between symptomatology and diagnosis of acromegaly. All patients underwent MRI scan of the pituitary as the primary mode of imaging. Pituitary adenomas were classified based on Hardy's classifications. (Table 1) . Diabetes mellitus associated with acromegaly was also taken into account. Patients who did not consent for the colonoscopy and in patients colonoscopy procedure was abandoned due to poor patient cooperation and patients with a family history of colonic neoplasms were excluded from the study. Patients who underwent only flexible sigmoidoscopy were also excluded from analysis. None of the patients had inflammatory bowel disease. The patients who consented for the colonoscopy were referred for a full-length colonoscopy. Colonoscopies were performed by consultant gastroenterologist using a 165 cm length colonoscope (Olympus, Tokyo, Japan). Bowel preparations were done using standard preparation with klean prep (Macrogol 3350, Sodium sulphate anhydrous, Sodium bicarbonate, Sodium chloride and Potassium chloride). All lesions were removed and these were subjected to histological examination and polyps were classified as adenomas, adenocarcinomas and hyperplastic polyps. 
Statistical analysis
Analysis of data was carried out using SPSS 20 version. Mean values and standard deviation were estimated for each continuous variable, such as age, duration on presentation, basal GH levels and duration of therapy while proportions were estimated for categorical variables. Chi square value was used to compare proportions while Student's t test was used to compare continuous variables. p<0.05 was considered as the level of significance.
Results
The mean age of the patients at diagnosis was 40.12 (SD±11.9) years and average lag time between symptomatology and diagnosis of acromegaly in these patients were 3.5 (SD ± 2.8) years. The basal mean plasma GH was 57.91 mU/L (SD±53.74) and mean plasma GH after 75 g oral glucose load was 51.22 mU/L (SD±45.47). On imaging, four patients (12.12%) had Grade I tumour while 28 (84.84%) had Grade II tumour and above. One patient (3.03%) had normal pituitary MRI. (Table 2) . Colonoscopic examination was complete to the caecum in 23 patients (69.69%), to the splenic flexure in eight patients (24.24%) and to hepatic flexure in the remaining two patients(6.06%) . Colonoscopy findings were abnormal in 11 (33.33%) patients. The findings on the colonoscopy were classified as follows. (Table 3) . Five patients(15%) with acromegaly had polyps in their colonoscopy. Three patients had the polyps in the transverse colon while one patient had it closer to the hepatic flexure and another patient had polyps in the rectum. On histopathology two of these polyps were classified as hyperplastic polyps. Two were classified as tubular adenoma with low grade dysplasia. One polyp which was removed completely was lost during the procedure. None of the patients had colonic carcinoma. The group of acromegalic patients with and without polyps did not differ significantly in age 39.8±13.3 years vs 39.71 ±11.34 years, (p= 0.326), in duration of disease 2.8 ±2.0 years vs 3.6±3.0 years, (p=0.544) or in circulating basal GH levels (77.13 ±64.91mU/L vs 42.61±42.70 mU/L, p= 0.134). Diabetes did not influence the prevalence of colonic polyps in acromegaly. Three out of the 15 diabetic acromegalic patients (20%) and two out of 18 nondiabetic acromegalic patients (11.1%) had polyps that was not statistically significant (p= 0.585). Having polyps was statistically significantly higher among male sex than female sex (p<0.05) but a conclusion cannot be made due to poor sample size. The detailed results are presented in table-4 and figure-1. Four out of the 5 acromegalic patients who had polyps had active disease when the colonoscopy was performed. (Table 5 ). 
Grade
Discussion
Colorectal neoplasms are well known complications of acromegaly and these patients are at increased risk of developing colorectal cancer. Several studies on prevalence of colorectal polyps in patients with acromegaly from western world, report widely between 23% and 53% (1-5).
Nevertheless at least two studies from the West failed to show increased prevalence of colonic neoplasia among acromegalics (8, 9) . It has also been suggested that the risk of colorectal cancers may be dependent on the geographic and ethnic origin of the patients. Data on the prevalence of colorectal neoplasms in Asian patients with acromegaly are limited. A recent study from Japan (10) showed an increased risk of colorectal neoplasms, especially colorectal adenocarcinomas (a prevalence of 38.6 % for hyperplastic polyps, 31.6 % for adenomas and 5.3 % for adenocarcinomas) whereas a study from India (11) data may be related to the differences among the study populations and the differences in methodology in different studies. Our study shows a prevalence of 15%, a frequency closer to the findings of at least 2 studies Brunner et al (12) (14%) and Larijani et a (13) (13%). We found premalignant lesions in 2 patients (6.06%).
Age is an important factor that could influence the prevalence rates of colonic adenomas in acromegalic patients. Our study failed to show an association between age and prevalence of colonic polyps which is in contrast with the studies by Jenkins et al (5) and Renehan et al (9) . They observed that the prevalence rates increased with each decade. The mean age of patients with acromegaly in different studies on colonic neoplasia has shown wide variation and this could influence the prevalence rates of polyps in the published studies.
Our study shows the prevalence of polyps was significantly increased in male acromegalic patients compared to female acromegalic patients. (p<0.05). Both Brunner et al (12) and Delhougne et al (1) have published similar results. Nevertheless, we are unable to arrive at a conclusion from our study due to poor sample size and this correlation may be established with a larger sample size. The duration of disease, basal GH levels and glycemic status did not differ significantly in acromegalic patients with and without polyps in the present study. Similar results were also observed by Bhansali et al (11) from India although in contrast to Matano et al (14) who suggest that high serum GH levels may be associated with the high presence of colonic polyps in acromegaly patients. Similarly, studies which looked for any association between IGF1 levels and the presence of colonic polyps also showed conflicting results. Dworakowska et a (15) and Dutta et al (16) showed elevated IGF1 levels are associated with high prevalence of colonic polyps whereas Larijani et al (13) and Jenkins et al (5) failed to show an association between IGF1 and presence of colonic polyps.
Wassenaar et al (17) showed that acromegaly is also associated with an increased prevalence of colonic diverticula. In their study colonic diverticula were present in 37% of patients with acromegaly. Interestingly 9% of our study population too had colonic diverticula. Although it has been suggested that this observation is due to the irreversible effect of GH and/or IGF-I on the collagen in the colon we need further studies on this finding.
Studies of acromegalic patients show colonoscopic examination may be technically difficult to be performed due to the increased bowel length and the loop complexity (6, 9) . Moreover; more vigorous colonic lavage (twice the "standard" amount of the osmotic purgative Klean-Prep) may be needed for satisfactory bowel preparation before colonoscopy (6) . These factors play an important role in a successful colonoscopic examination which in turn could affect the prevalence rate of the polyps. We used the standard bowel preparation in our study, but further studies following vigorous colonic lavage need to be carried out in future to find out the true prevalence. Small sample size was the main limitation of our study; however, this does not invalidate our findings and prospective studies with sufficient power are required to investigate the true prevalence of colonic polyps in patients with acromegaly.
Conclusion
Despite lower prevalence of colonic polyps (15%) compared to studies from west we still found premalignant lesions in 2 patients (6.06%). Therefore, we suggest that acromegalic patients should undergo screening colonoscopy.
